36236-76-7

Basic information

• Product Name: 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane
• Synonyms: 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane;4-(BroMoMethyl)-2,2-diMethyl-1,3-dioxolane;DL-Isopropylideneglycerol-1-bromohydrin
• CAS NO: 36236-76-7
• Molecular Formula: C₆H₁₁BrO₂
• Molecular Weight: 195.05434
• EINECS: 604-604-1
• Mol File: 36236-76-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 75℃ (10 Torr)
• Flash Point: 74.8°C
• Appearance: /
• Density: 1.359g/cm³
• Vapor Pressure: 0.688mmHg at 25°C
• Refractive Index: 1.4597 (589.3 nm 20℃)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane(36236-76-7)
• EPA Substance Registry System: 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane(36236-76-7)

Safety Data

• RIDADR: 1993
• HazardClass: 3
• PackingGroup: Ⅲ
• Hazardous Substances Data: 36236-76-7(Hazardous Substances Data)

Usage

General Description

4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane is a chemical compound with the formula C7H13BrO2. Its Molecular Weight is 213.08. It is a member of the acetals family, which are organic compounds characterized by the presence of two alkoxy or aryloxy groups attached to the same carbon atom. This particular compound is a valuable reagent in organic synthesis processes due to its bromomethyl moiety which allows for a variety of reactions, including those involving cross-linking, joining, or extending molecular chains. Despite being a useful chemical, it should be handled cautiously as it can pose health hazards when improperly handled. Proper safety procedures should be employed whenever this compound is in use. The chemical stability, physical property, and storage conditions of 4-(Bromomethyl)-2,2-dimethyl-1,3-dioxalane depend greatly on the specific requirements for usage.

InChI:InChI=1/C6H11BrO2/c1-6(2)8-4-5(3-7)9-6/h5H,3-4H2,1-2H3

Upstream product

• 34832-91-2 1,2-O-isopropylideneglyceryl N,N,N'N,-tetraethylphosphorodiamidite 
• 4704-77-2 1-bromo-2,3-propanediol 
• 584-08-7 potassium carbonate 
• 776-74-9 Bromodiphenylmethane 
• 67-64-1 acetone 
• 3132-64-7 1,2-Epoxy-3-bromopropane 
• 77-76-9 2,2-dimethoxy-propane 

Downstream Products

• 137275-78-6 4-[(4-hydroxyphenoxy)methyl]-2,2-dimethyl-1,3-dioxolane 
• 804511-26-0 2-(((2-(1-benzofuran-2-yl)-2-hydroxyethyl)(methyl)amino)methyl)-N-(4-chlorobenzyl)-7-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamide 
• 804511-32-8 N-(4-chlorobenzyl)-7-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-2-((((2R)-2-(2-furyl)-2-hydroxyethyl)(methyl)amino)methyl)-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamide 
• 672326-05-5 2-(chloromethyl)-N-((4-chlorophenyl)methyl)-7-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-4,7-dihydro-4-oxothieno[2,3-b]-pyridine-5-carboxamide 
• 84508-72-5 4-benzylaminomethyl-2,2-dimethyl-1,3-dioxolane 
• 1038914-88-3 N-[2-(N-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-1H-indol-3-yl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl)acetamide 
• 1082746-58-4 3,23-dihydroxy-20⁽²⁹⁾-lupen-28-oic acid 2,2-dimethyl-1,3-dioxolane-4-yl methyl ester 
• 1019878-04-6 1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-3-(2-methylphenyl)-4-(pyridin-4-yl)quinolin-2(1H)-one 
• 1019878-11-5 2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-(2-methylphenyl)-4-(pyridin-4-yl)quinoline 
• 1019877-86-1 C₂₆H₂₃FN₂O₃ 
• 1019877-80-5 1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-3-(4-fluorophenyl)-4-(pyridin-4-yl)quinolin-2(1H)-one 
• 672326-03-3 N-(4-chlorobenzyl)-7-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-2-(hydroxymethyl)-4-oxo-4,7-dihydrothieno[2,3-b]-pyridine-5-carboxamide 
• 595568-01-7 bis-((2,2-dimethyl)-[1,3]dioxolan-4-yl-methyl)-benzylamine 
• 142103-85-3 5-[2-Amino-5-(2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-benzyl]-imidazolidine-2,4-dione 

Relevant articles and documents

-

-

A method of synthesis of alkyl iodides and bromides

-

Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions

Quaternary amine-containing ether lipid analogs of the formula are disclosed. R1 represents a hydrophobic group and R2 represents the backbone of the molecule, with the quaternary amine being linked directly to the backbone. Pharmaceutical compositions including these compounds and methods of combating tumors with these compounds are disclosed. Also disclosed is a method of combating viral infections with both these compounds and ET-18-OMe and its analogs.